Your browser doesn't support javascript.
loading
Deriving an optimal threshold of waist circumference for detecting cardiometabolic risk in sub-Saharan Africa.
Ekoru, K; Murphy, G A V; Young, E H; Delisle, H; Jerome, C S; Assah, F; Longo-Mbenza, B; Nzambi, J P D; On'Kin, J B K; Buntix, F; Muyer, M C; Christensen, D L; Wesseh, C S; Sabir, A; Okafor, C; Gezawa, I D; Puepet, F; Enang, O; Raimi, T; Ohwovoriole, E; Oladapo, O O; Bovet, P; Mollentze, W; Unwin, N; Gray, W K; Walker, R; Agoudavi, K; Siziya, S; Chifamba, J; Njelekela, M; Fourie, C M; Kruger, S; Schutte, A E; Walsh, C; Gareta, D; Kamali, A; Seeley, J; Norris, S A; Crowther, N J; Pillay, D; Kaleebu, P; Motala, A A; Sandhu, M S.
Afiliação
  • Ekoru K; Sandhu Group, Department of Medicine, University of Cambridge, Cambridge, UK.
  • Murphy GAV; Global Health and Populations Group, Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK.
  • Young EH; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Delisle H; Sandhu Group, Department of Medicine, University of Cambridge, Cambridge, UK.
  • Jerome CS; Global Health and Populations Group, Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK.
  • Assah F; Department of Nutrition, Faculty of Medicine, University of Montreal, Montreal, Canada.
  • Longo-Mbenza B; Regional Institute of Public Health, University of Abomey-Calavi, Cotonou, Benin.
  • Nzambi JPD; Department of Public Health, Faculty of Medicine and Biomedical Sciences, University of Yaounde I, Yaounde, Cameroon.
  • On'Kin JBK; Faculty of Health Sciences, Walter Sisulu University, Eastern Cape, South Africa.
  • Buntix F; Department of Basic Sciences, Unit of Clinical Pharmacology and Pharmacovigilance, Faculty of Medicine, University of Kinshasa, Kinshasa, DR Congo.
  • Muyer MC; Department of Internal Medicine, Faculty of Medicine, University of Kinshasa, Kinshasa, DR Congo.
  • Christensen DL; Department of General Practice, KU Leuven, Leuven, Belgium.
  • Wesseh CS; Department of Public Health, University of Kinshasa, Kinshasa, DR Congo.
  • Sabir A; Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
  • Okafor C; Ministry of Health and Social Welfare, Monrovia, Liberia.
  • Gezawa ID; Department of Medicine, Usmanu Danfodiyo University Teaching Hospital, Sokoto, Nigeria.
  • Puepet F; Department of Medicine & Physiology, Faculty of Medical Sciences, University of Nigeria, Enugu Campus/University of Nigeria Teaching Hospital, Ituku Ozalla, Enugu, Nigeria.
  • Enang O; Department of Medicine, College of Health Sciences, Bayero University Kano/Aminu Kano Teaching Hospital, Kano State, Kano, Nigeria.
  • Raimi T; Department of Medicine, College of Medical Sciences, University of Jos, Jos, Nigeria.
  • Ohwovoriole E; Department of Internal Medicine, University of Calabar/University of Calabar Teaching Hospital, Calabar, Nigeria.
  • Oladapo OO; Department of Medicine, Ekiti State University, Ado-Ekiti, Nigeria.
  • Bovet P; Department of Medicine, College of Medicine, University of Lagos, Lagos, Nigeria.
  • Mollentze W; Division of Cardiovascular Medicine, Department of Medicine (University College Hospital), College of Medicine, University of Ibadan, Ibadan, Nigeria.
  • Unwin N; Institute of Social and Preventive Medicine, University of Lausanne, Lausanne, Switzerland.
  • Gray WK; University of the Free State, Bloemfontein, Republic of South Africa.
  • Walker R; MRC Epidemiology Unit, University of Cambridge, Cambridge, UK.
  • Agoudavi K; Northumbria Healthcare NHS Foundation Trust, North Tyneside General Hospital, North Shields, Tyne and Wear, UK.
  • Siziya S; Northumbria Healthcare NHS Foundation Trust, North Tyneside General Hospital, North Shields, Tyne and Wear, UK.
  • Chifamba J; Institute of Health and Society, Newcastle University, Newcastle, UK.
  • Njelekela M; National NCD Program, Ministry Of Health, Lome, Togo.
  • Fourie CM; School of Medicine, The Copperbelt University, Ndola, Zambia.
  • Kruger S; Physiology Department, University of Zimbabwe, College of Health Sciences, Harare, Zimbabwe.
  • Schutte AE; Department of Physiology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
  • Walsh C; HART (Hypertension in Africa Research Team), North-West University, Potchefstroom, South Africa.
  • Gareta D; Africa Unit for Transdisciplinary Health Research (AUTHeR), North-West University, Potchefstroom, South Africa.
  • Kamali A; MRC Unit for Hypertension and Cardiovascular Disease, North-West University, Potchefstroom, South Africa.
  • Seeley J; HART (Hypertension in Africa Research Team), North-West University, Potchefstroom, South Africa.
  • Norris SA; MRC Unit for Hypertension and Cardiovascular Disease, North-West University, Potchefstroom, South Africa.
  • Crowther NJ; Department of Nutrition and Dietetics, University of the Free State, Bloemfontein, South Africa.
  • Pillay D; Wellcome Trust Africa Centre for Health and Population Studies, University of KwaZulu-Natal, KwaZulu-Natal, South Africa.
  • Kaleebu P; MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.
  • Motala AA; MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.
  • Sandhu MS; MRC/Wits Developmental Pathways for Health Research Unit (DPHRU), University of the Witwatersrand, Johannesburg, South Africa.
Int J Obes (Lond) ; 2017 Oct 03.
Article em En | MEDLINE | ID: mdl-29087388
BACKGROUND: Waist circumference (WC) thresholds derived from western populations continue to be used in sub-Saharan Africa (SSA) despite increasing evidence of ethnic variation in the association between adiposity and cardiometabolic disease and availability of data from African populations. We aimed to derive a SSA-specific optimal WC cut-point for identifying individuals at increased cardiometabolic risk. METHODS: We used individual level cross-sectional data on 24 181 participants aged ⩾15 years from 17 studies conducted between 1990 and 2014 in eight countries in SSA. Receiver operating characteristic curves were used to derive optimal WC cut-points for detecting the presence of at least two components of metabolic syndrome (MS), excluding WC. RESULTS: The optimal WC cut-point was 81.2 cm (95% CI 78.5-83.8 cm) and 81.0 cm (95% CI 79.2-82.8 cm) for men and women, respectively, with comparable accuracy in men and women. Sensitivity was higher in women (64%, 95% CI 63-65) than in men (53%, 95% CI 51-55), and increased with the prevalence of obesity. Having WC above the derived cut-point was associated with a twofold probability of having at least two components of MS (age-adjusted odds ratio 2.6, 95% CI 2.4-2.9, for men and 2.2, 95% CI 2.0-2.3, for women). CONCLUSION: The optimal WC cut-point for identifying men at increased cardiometabolic risk is lower (⩾81.2 cm) than current guidelines (⩾94.0 cm) recommend, and similar to that in women in SSA. Prospective studies are needed to confirm these cut-points based on cardiometabolic outcomes.International Journal of Obesity advance online publication, 31 October 2017; doi:10.1038/ijo.2017.240.

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article